Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ZNFX1 promotes AMPK-mediated autophagy against Mycobacterium tuberculosis by stabilizing Prkaa2 mRNA
Honglin Liu, Zhenyu Han, Liru Chen, Jing Zhang, Zhanqing Zhang, Yaoxin Chen, Feichang Liu, Ke Wang, Jieyu Liu, Na Sai, Xinying Zhou, Chaoying Zhou, Shengfeng Hu, Qian Wen, Li Ma
Honglin Liu, Zhenyu Han, Liru Chen, Jing Zhang, Zhanqing Zhang, Yaoxin Chen, Feichang Liu, Ke Wang, Jieyu Liu, Na Sai, Xinying Zhou, Chaoying Zhou, Shengfeng Hu, Qian Wen, Li Ma
View: Text | PDF
Research Article Immunology Infectious disease

ZNFX1 promotes AMPK-mediated autophagy against Mycobacterium tuberculosis by stabilizing Prkaa2 mRNA

  • Text
  • PDF
Abstract

Tuberculosis has the highest mortality rate worldwide for a chronic infectious disease caused by a single pathogen. RNA-binding proteins (RBPs) are involved in autophagy — a key defense mechanism against Mycobacterium tuberculosis (M. tuberculosis) infection — by modulating RNA stability and forming intricate regulatory networks. However, the functions of host RBPs during M. tuberculosis infection remain relatively unexplored. Zinc finger NFX1-type containing 1 (ZNFX1), a conserved RBP critically involved in immune deficiency diseases and mycobacterial infections, is significantly upregulated in M. tuberculosis–infected macrophages. Here, we aimed to explore the immunoregulatory functions of ZNFX1 during M. tuberculosis infection. We observed that Znfx1 knockout markedly compromised the multifaceted immune responses mediated by macrophages. This compromise resulted in reduced phagocytosis, suppressed macrophage activation, increased M. tuberculosis burden, progressive lung tissue injury, and chronic inflammation in M. tuberculosis–infected mice. Mechanistic investigations revealed that the absence of ZNFX1 inhibited autophagy, consequently mediating immune suppression. ZNFX1 critically maintained AMPK-regulated autophagic flux by stabilizing protein kinase AMP-activated catalytic subunit alpha 2 mRNA, which encodes a key catalytic α subunit of AMPK, through its zinc finger region. This process contributed to M. tuberculosis growth suppression. These findings reveal a function of ZNFX1 in establishing anti–M. tuberculosis immune responses, enhancing our understanding of the roles of RBPs in tuberculosis immunity and providing a promising approach to bolster antituberculosis immunotherapy.

Authors

Honglin Liu, Zhenyu Han, Liru Chen, Jing Zhang, Zhanqing Zhang, Yaoxin Chen, Feichang Liu, Ke Wang, Jieyu Liu, Na Sai, Xinying Zhou, Chaoying Zhou, Shengfeng Hu, Qian Wen, Li Ma

×

Figure 7

Stabilization of Prkaa2 mRNA by ZNFX1 through interaction with its zinc finger region.

Options: View larger image (or click on image) Download as PowerPoint
Stabilization of Prkaa2 mRNA by ZNFX1 through interaction with its zinc ...
(A) Western blotting of ZNFX1 in the cytosol, membrane, and nucleus fraction of BMDMs. (B) qPCR analysis of Prkaa1 and Prkaa2 in Znfx1–/– BMDMs treated with DRB (n = 3). (C) qPCR analysis of Prkaa2 in WT and Znfx1–/– BMDMs infected with LV-Prkaa2 (n = 3). LV, lentiviral. (D) RIP assay using anti-ZNFX1 antibody and qPCR analysis of the association between ZNFX1 protein and Prkaa1 and Prkaa2 mRNA in BMDMs (n = 3). (E) RNA pulldown assay using biotinylated Prkaa2 and GFP transcripts and Western blotting of the association between Prkaa2 mRNA and ZNFX1 protein in BMDMs. (F) Schematic diagram of recombinant plasmids carrying full-length or various truncated forms of the Znfx1 gene accompanied by a FLAG tag. (G) RIP assay using anti-FLAG antibody and qPCR analysis of the association between full-length or truncated forms of ZNFX1 protein and Prkaa2 mRNA in HEK293T cells transfected with various Znfx1 expression plasmids (n = 5). (H) qPCR analysis of Prkaa2 in HEK293T cells transfected with various Znfx1 expression plasmids and treated with DRB (n = 3). (I) CFU assay of M. tuberculosis load in WT and Znfx1–/– BMDMs transfected with the F2 truncated form of Znfx1 (n = 4). (J) Schematic diagram of the molecular mechanism of ZNFX1 in the regulation of autophagy against M. tuberculosis infection. OE, overexpression. A 2-way ANOVA with Holm-Šídák post hoc test (D and I) or a 1-way ANOVA followed by multiple-comparison test (G) was used for statistical analysis. Data are presented as mean ± SD and are representative of at least 3 experiments with similar observations. ***P < 0.001; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts